z-logo
open-access-imgOpen Access
P09.63 Postmortem evaluation of end-organ toxicity in patients with glioblastoma treated with temozolomide, bevacizumab and irinotecan
Author(s) -
G. Lu,
M. R. S. Rao,
Ping Zhu,
Xuejun Tian,
Nadine Linendoll,
Monika Pilichowska,
William F. Glass,
R Hunter,
Jiang Zhu
Publication year - 2017
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/nox036.318
Subject(s) - temozolomide , medicine , bevacizumab , irinotecan , autopsy , oncology , glioma , toxicity , chemotherapy , cancer , pathology , colorectal cancer , cancer research

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom